The second edition of this important book provides an up-to-date and comprehensive overview of clinical lipidology. Brand new chapters focus on recent advances in the field including novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, imaging technologies, and epidemiology of atherosclerotic cardiovascular disease.

The book describes new guidelines, novel therapeutic agents, and changes in the understanding of specific lipoproteins and subclasses with regard to their relationships to cardiovascular disease risk. The second edition contains more than thirty chapters covering such topics as the history of lipidology, lipoprotein metabolism and vascular biology, disorders of lipid metabolism, lifestyle/dietary and pharmacologic management for dyslipidemia, the management of dyslipidemia in certain subgroups (e.g., women, children, older patients) and lipid testing, as well as an examination of other biomarkers and testing procedures related toatherosclerosis and cardiovascular disease. 

The second edition of Therapeutic Lipidology is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

<p>Chapter 1. History of Lipidology

Chapter 2. Atherogenesis and Vascular Biology
Chapter 3. Genetic Disorders of Lipoprotein Metabolism
Chapter 4. Cardiovascular Genomics
Chapter 5. Epidemiology of Atherosclerotic Cardiovascular Disease
Chapter 6. Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines
Chapter 7. The Low-Density Lipoprotein Cholesterol Hypothesis:  An Update
Chapter 8. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk
Chapter 9. Medical Nutrition Therapy for Lipid and Lipoprotein Disorders.- Chapter 10. Nutraceuticals and Lipid Management
Chapter 11. Pharmacology of Statins
Chapter 12. Management of Statin Intolerance
Chapter 13. Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins and Plant Sterols
Chapter 14. Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and its Therapeutic Inhibition
Chapter 15. Management of Hypertriglyceridemia (Including Fibrates and n-3 Fatty Acids)
Chapter 16. Pathophysiology and Management of Dyslipidemias Associated with Insulin-resistant States
Chapter 17. Therapeutic Management of Obesity
Chapter 18. High Density Lipoproteins
Chapter 19. Lipoprotein (a): Principles from Bench to Bedside.- Chapter 20. Management of Homozygous Familial Hypercholesterolemia
Chapter 21. Lysosomal Acid Lipase Deficiency
Chapter 22. Lipodystrophies
Chapter 23. HIV and Dyslipidemia
Chapter 24. Cardiovascular Disease in Women: Focus on Lipid Management
Chapter 25. Management of Dyslipidemia in the Elderly
Chapter 26. Management of Dyslipidemia in Children
Chapter 27. Lipoprotein Subfractions in Clinical Practice
Chapter 28. Ion Mobility Lipoprotein Analysis
Chapter 29. How ApoB Measurements Could Improve Prevention of Cardiovascular Disease
Chapter 30. C-reactive Protein and Other Inflammatory Markers in Cardiovascular Disease; Inflammatory Disorders and Atherosclerosis
Chapter 31. Coronary Artery Calcium and CT Angiography
Chapter 32. The Clinical Use of Ultrasound for Atherosclerosis Imaging
Chapter 33. Emerging Therapies for Regulating Dyslipidemias and Atherosclerosis.- Chapter 34. The Allied Health Professional's Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program
Chapter 35. The American Board of Clinical Lipidology Physician Certification Program.</p><p></p>